|
Demographic
|
|
|
|
|
| Female sex |
17 |
40 |
3 |
30 |
| Age, median (min-max) |
56 (25–75) |
|
60 (19–74) |
|
| No of fever days (min-max) |
2 (1–20) |
|
2 (1–14) |
|
|
|
|
|
|
|
Hematologic disease
|
|
|
|
|
| Acute myeloid leukemia |
15 |
36 |
4 |
40 |
| Malignant lymphoma |
11 |
26 |
2 |
20 |
| Multiple myeloma/plasma cell leukemia |
8 |
19 |
2 |
20 |
| Acute lymphoblastic leukemia |
4 |
9.5 |
1 |
10 |
| Chronic lymphocytic leukemia |
3 |
7.1 |
0 |
0 |
| Other disorders |
1 |
2.4 |
1 |
10 |
|
|
|
|
|
|
Hematopoietic stem cell transplantation
|
|
|
|
|
| Autologous |
4 |
9.5 |
1 |
10 |
| Allogeneic |
6 |
14 |
1 |
10 |
|
|
|
|
|
|
Immunosuppressive treatment
|
|
|
|
|
| Chemotherapy, ongoing |
2 |
4.8 |
1 |
10 |
| Corticosteroids, systemic |
8 |
19 |
2 |
20 |
| Cyclosporin A, ongoing |
5 |
12 |
1 |
10 |
| Immunosuppression, previous 3 months |
42 |
100 |
10 |
100 |
|
|
|
|
|
|
Supportive treatment
|
|
|
|
|
| Granulocyte-colony stimulating factor |
7 |
17 |
4 |
40 |
| Total parenteral nutrition |
13 |
31 |
3 |
30 |
|
|
|
|
|
|
Ongoing antibiotics
|
|
|
|
|
| Antibacterial |
36 |
86 |
10 |
100 |
| Antifungal |
24 |
57 |
5 |
50 |
| Antiviral |
38 |
90 |
9 |
90 |
